2 completed, 1 recruiting, 1 unknown. 3 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Cone biopsy: new trials by email Literature Review of Cone biopsy trials Research Report on Cone biopsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer Cadonilimab, Paclitaxel-albumin, Cisplatin - Cervical Cancer, Neoadjuvant Chemoimmunotherapy | Phase 2 | Recruiting | Tongji Hospital | 50 | 2024-09-03 | 2024-09-19 |
| See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia Cone biopsy - Cervical Dysplasia, Cervical Lesion | Not applicable | Completed | University of Aarhus | 109 | 2019-03-13 | 2022-05-18 |
| Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer Conization, Quality-of-Life Assessment, Questionnaire Administration - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Not applicable | Unknown | GOG Foundation | 224 | 2013-06-05 | 2024-05-03 |
| Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer Cervical Papanicolaou Test, Conization, Laboratory Biomarker Analysis - Precancerous Condition, Stage 0 Cervical Cancer | Not applicable | Completed | Gynecologic Oncology Group | 684 | 1998-09-01 | 2015-05-29 |
Uterine Cervical Dysplasia (2) · Lymphedema (1) · Precancerous Conditions (1) · Uterine Cervical Diseases (1) · Uterine Cervical Neoplasms (1)
GOG Foundation (1) · Gynecologic Oncology Group (1) · Tongji Hospital (1) · University of Aarhus (1)
United States (2) · Canada (1) · China (1) · Denmark (1) · South Korea (1)
Allan L Covens (1) · Ding Ma (1) · Line W Gustafson, MD (1) · Shu-Yuan Liao (1)
PMID 32894896, PMID 37650664, PMID 40654017, PMID 41582028
U10CA101165 (1), U10CA180868 (1), UG1CA189867 (1)